John Goulding

John (Bobby) Goulding is a highly experienced researcher and leader in the field of cell therapy and immunology, currently serving as the Director of Research Development and Principal Scientist at Fate Therapeutics Inc since January 2020. Bobby also holds the position of AI Digital Biologist Advisor at ThinkingNode Life Science, Inc., focusing on developing AI models for patient-specific cell therapies. Prior to these roles, Bobby worked at NantKwest, leading CAR NK cell platform development, and held various academic positions, including post-doctoral research at the University of California, San Diego, and the La Jolla Institute for Allergy and Immunology. Bobby earned a Ph.D. in Biochemistry and Inflammation Immunology from Imperial College London, complemented by an MPhil in Bioscience Enterprise from the University of Cambridge and a BSc in Biochemistry from Imperial College London.